Quantum Biopharma Ltd. | WebDisclosure

Basculer en Français

10417	Companies
218097	Keywords
147644	Articles
115404	Press releases

Headlines Articles Press releases Quantum Biopharma Ltd.

Home
Companies
Quantum Biopharma Ltd.

PRESS RELEASE

published on 12/20/2024 at 15:15, 1 year 4 months ago

Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
Quantum BioPharma Ltd. purchases $1,000,000 Bitcoin and other cryptocurrencies, allows cryptocurrency transactions, emphasizing compliance and potential returns for shareholders

Bitcoin Compliance Investment Cryptocurrency Quantum BioPharma
BRIEF

published on 12/14/2024 at 01:05, 1 year 5 months ago

Quantum BioPharma conclut la première tranche de son offre

Première Tranche Biopharmacie Quantique Unités D'obligations Développement Du Capital Dollars Canadiens
BRIEF

published on 12/14/2024 at 01:05, 1 year 5 months ago

Quantum BioPharma Concludes Initial Tranche of Offering

First Tranche Capital Development Quantum BioPharma Canadian Dollars Debenture Units
PRESS RELEASE

published on 12/14/2024 at 01:00, 1 year 5 months ago

Quantum Biopharma Announces Closing of First Tranche
Quantum BioPharma closes initial tranche of offering, issuing 500 Debenture Units for $500,000. Proceeds for business development and working capital. Securities subject to statutory hold period

Working Capital Statutory Hold Period Quantum BioPharma Debenture Units Tranche Offering
BRIEF

published on 12/10/2024 at 13:35, 1 year 5 months ago

Quantum Biopharma avance dans l'essai clinique Lucid-MS

Recherche Biopharmaceutique Biopharmacie Quantique Examen De Sécurité Essai Lucid-MS Progrès Clinique
BRIEF

published on 12/10/2024 at 13:35, 1 year 5 months ago

Quantum Biopharma Moves Forward in Lucid-MS Clinical Trial

Biopharmaceutical Research Quantum BioPharma Lucid-MS Trial Clinical Advancement Safety Review
PRESS RELEASE

published on 12/10/2024 at 13:30, 1 year 5 months ago

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)
Quantum BioPharma announces approval to proceed with dosing of second cohort in Lucid-21-302 trial. Company focused on innovative treatments for neurodegenerative disorders

Drug Development Neurodegenerative Disorders Quantum BioPharma Lucid-21-302 Trial Safety Review Committee
BRIEF

published on 12/05/2024 at 13:35, 1 year 5 months ago

Quantum BioPharma Launches Private Placement for $5 Million

Private Placement Convertible Debenture Canadian Market Investment Offering Quantum BioPharma
BRIEF

published on 12/05/2024 at 13:35, 1 year 5 months ago

Quantum BioPharma lance un placement privé de 5 millions de dollars

Placement Privé Marché Canadien Obligation Convertible Biopharmacie Quantique Offre D'investissement
PRESS RELEASE

published on 12/05/2024 at 13:30, 1 year 5 months ago

Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million
Quantum BioPharma announces a non-brokered private placement offering of convertible debenture units. Proceeds for business development and working capital

Private Placement Working Capital Business Development Quantum BioPharma Debenture Units

Accesswire

Published on 05/18/2026 at 22:30, 3 hours 12 minutes ago

Ondas Inc. Stockholders: Vote Now to Ensure Quorum for Annual Meeting
Published on 05/18/2026 at 14:37, 11 hours 5 minutes ago

Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
Published on 05/18/2026 at 14:30, 11 hours 12 minutes ago

Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides
Published on 05/18/2026 at 08:01, 17 hours 41 minutes ago

Result of Fundraise
Published on 05/17/2026 at 15:20, 1 day 10 hours ago

China XLX Announces 2026 Q1 Results

View all ACCESSWIRE

EQS Group

Published on 05/18/2026 at 20:54, 4 hours 48 minutes ago

Freelance.com: chiffre d’Affaires 1er trimestre 2026 : 275,3 M€ (+4%)
Published on 05/18/2026 at 20:40, 5 hours 1 minute ago

Aramco and Pasqal launch Saudi Arabia's first Quantum Computer and Middle East's first commercial Quantum Computing as a Service platform
Published on 05/18/2026 at 20:35, 5 hours 7 minutes ago

Africa Finance Corporation Approves US$100 Million Commitment to Africa-Focused Technology Fund Managers to Accelerate Africa’s Digital Industrialisation
Published on 05/18/2026 at 19:38, 6 hours 3 minutes ago

Holding(s) in Company
Published on 05/18/2026 at 19:00, 6 hours 42 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 11 MAI 2026 au 15 MAI 2026

Les Echos

Published on 05/18/2026 at 22:25, 3 hours 17 minutes ago

Résultats de l’offre publique de retrait et mise en œuvre du retrait obligatoire à venir sur les titres TERACT
Published on 05/18/2026 at 22:25, 3 hours 17 minutes ago

Results of the public buy-out offer and implementation of the subsequent squeeze-out of TERACT shares
Published on 05/18/2026 at 18:36, 7 hours 5 minutes ago

Déclaration des transactions sur actions propres réalisées du 11/05/2026 au 17/05/2026
Published on 05/18/2026 at 18:30, 7 hours 12 minutes ago

ALPOU - Groupe POULAILLON - Dépôt du projet de note en réponse à l'offre publique d'achat simplifiée
Published on 05/18/2026 at 18:23, 7 hours 18 minutes ago

260518 BENETEAU Transactions sur actions propres

View all LES ECHOS COMFI WIRE